AEON Biopharma, Inc. Class A AEON
AMEX · United States · Health Technology
$0.2600-0.03 (-10.34%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.02 | -0.23 | +91.1% | $0 | — | -0.7%$0.27→$0.27 |
| Q1 2026 | 2026-05-14 | -0.44 | — | — | — | — | -12.0%$0.82→$0.72 |
| Q4 2025 | 2026-03-30 | -3.72 | -0.20 | -1,760.0% | — | — | -15.1%$1.16→$0.99 |
| Q3 2025 | 2025-11-14 | -0.39 | -0.43 | +9.3% | — | — | -7.4%$0.94→$0.87 |
| Q2 2024 | 2024-08-12 | 5.34 | -13.68 | +139.0% | — | — | — |
| Q4 2023 | 2024-03-29 | -51.12 | -28.80 | -77.5% | — | — | — |
| Q3 2023 | 2023-11-13 | 82.80 | -38.16 | +317.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.